NAMS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

NewAmsterdam Pharma Company NV (NAMS) Moving Averages Convergence Divergence (MACD) indicator is 0.705, suggesting NAMS is Buy.

NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 34.891, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.68, making it Sell.

NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 32.639, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.68, making it Buy.

Technical Analysis for NAMS

Technical Sentiment Analysis for NewAmsterdam Pharma Company NV (NAMS) As of 2026-05-29, NewAmsterdam Pharma Company NV (NAMS) is exhibiting a Buy technical sentiment. Our proprietary analysis, which aggregates 12 technical signals, shows that 7 indicators are flashing buy, while 5 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for NAMS stands at 47.226, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.705, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 27.824 and the Commodity Channel Index (CCI) at -13.28 further confirm a -3.2 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, NAMS is trading below its 60-day moving average of $32.639 and below its 200-day long-term moving average of $32.855. Key price levels to watch include the immediate resistance at $37.373 and strong support at $32.993. A break above $37.373 could signal a bull continuation, while falling below $32.993 may test the next Fibonacci floor at $30.787.

NewAmsterdam Pharma Company NV (NAMS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	28.613	30.787	32.993	35.167	37.373	39.547	41.753
Fibonacci	30.787	32.46	33.494	35.167	36.84	37.874	39.547

NewAmsterdam Pharma Company NV (NAMS) Technical Indicators

2026-05-29

Name	Value
RSI_14	47.226
STOCHk_14_3_3	27.824
STOCHd_14_3_3	39.763
CCI_20	-13.28
AO_5_34	1.92
MOM_10	-3.2
MACD_12_26_9	0.705

NewAmsterdam Pharma Company NV (NAMS) Relative Strength Index (RSI) is 47.226, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Stochastic Oscillator is 27.824, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Stochastic RSI is 39.763, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Commodity Channel Index (CCI) is -13.28, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Awesome Oscillator is 1.92, creating a Buy signal.

NewAmsterdam Pharma Company NV (NAMS) Momentum is -3.2, creating a Sell signal.

NewAmsterdam Pharma Company NV (NAMS) MACD is 0.705, creating a Buy signal.

NewAmsterdam Pharma Company NV (NAMS) Moving Average

2026-05-29

Period	Simple	Signal
MA_5	35.442	Sell
MA_10	35.2	Sell
MA_20	34.891	Sell
MA_60	32.639	Buy
MA_200	32.855	Buy
MA_250	30.475	Buy

NewAmsterdam Pharma Company NV (NAMS) 5-Day simple moving average is 35.442, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.68, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 10-Day simple moving average is 35.2, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.68, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 34.891, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.68, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 32.639, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.68, making it a Buy.

NewAmsterdam Pharma Company NV (NAMS) 200-Day simple moving average is 32.855, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.68, making it a Buy.

NewAmsterdam Pharma Company NV (NAMS) 250-Day simple moving average is 30.475, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.68, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for NAMS?

The overall technical consensus for NewAmsterdam Pharma Company NV (NAMS) is currently Buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 4 buy signals and 2 sell signals.

What are the key support and resistance levels for NewAmsterdam Pharma Company NV (NAMS) today?

Based on pivot point calculations, NewAmsterdam Pharma Company NV (NAMS) has an immediate support level at 32.993 and a major resistance level at 37.373. Traders also monitor the pivot point at 35.167 to determine the intraday trend direction.

Is NewAmsterdam Pharma Company NV (NAMS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for NewAmsterdam Pharma Company NV (NAMS) is currently 47.226. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for NewAmsterdam Pharma Company NV (NAMS)?

NewAmsterdam Pharma Company NV (NAMS) Moving Averages Convergence Divergence (MACD) indicator is 0.705, suggesting NAMS is Buy. This indicator helps identify potential trend reversals or momentum shifts for NewAmsterdam Pharma Company NV.

How is NewAmsterdam Pharma Company NV (NAMS) performing relative to its 200-day moving average?

NewAmsterdam Pharma Company NV (NAMS) is currently trading at $33.68, which is above its 200-day simple moving average of 32.855. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.